ROCHESTER, N.Y., Aug. 14 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. , a leading developer of image-related biomarker solutions, announced today the board of directors’ appointment of Jeffrey Markin as the new president and chief executive officer. The board of directors also elected Bob Klimasewski, former acting CEO, as vice chairman of the board and added Jeff Markin to the board. Klimasewski will maintain an office at VirtualScopics and assist Markin during this transition period.
Markin joined VirtualScopics as chief operating officer in May, 2006. In his new role, he will be responsible for the day-to-day operations and corporate strategy, as well as acting as the external contact with the investor community.
“Since joining VirtualScopics, Markin has demonstrated that he is the right person for the job,” said Warren Bagatelle, chairman of VirtualScopics. “With his proven track record, we are confident he will be able to continue VirtualScopics’ development both on the business and financial fronts. We are also pleased that Klimasewski will be continuing to play an active role at the company.”
Prior to VirtualScopics, Markin was with Eastman Kodak Company for 26 years, most recently in the health group as vice president and general manager of output systems and mammography solutions. Previously, Markin held leadership positions in the document imaging business, including vice president of North American marketing, global general manager of the output business and general manager of the Asian-based services business with operations in China, Hong Kong, Philippines, Malaysia and Australia. Markin is a Six Sigma Management Black Belt.
About VirtualScopics, Inc.
VirtualScopics, Inc. is a provider of advanced medical image analysis services. The company evolved from research first carried out at the University of Rochester Medical Center and School of Engineering. VirtualScopics has created a suite of image analysis tools used in detecting and analyzing specific structures in volumetric medical images, as well as characterizing minute changes in structures over time, providing vital information to support clinical trials and diagnostic applications. The firm’s proprietary software algorithms can assemble hundreds of separate medical images taken during an MRI session into a single, three-dimensional model, bringing a new and previously unobtainable source of data to clinical researchers. For more information about VirtualScopics, visit www.virtualscopics.com.
Forward-Looking Statements
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby. Forward-looking statements deal with the Company’s current plans, intentions, beliefs and expectations. Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed from time to time in reports filed by the Company with the Securities and Exchange Commission.
CONTACT: Tracy Bagatelle-Black Bagatelle-Black Public Relations 661/263-1842 tracy@bagatelleblack.com
VirtualScopics, Inc
CONTACT: Tracy Bagatelle-Black of Bagatelle-Black Public Relations,+1-661-263-1842, or tracy@bagatelleblack.com
Web site: http://www.virtualscopics.com/
